OTC smoking cessation therapy Medicaid coverage required in latest Senate tobacco bill.
This article was originally published in The Tan Sheet
Executive Summary
OTC SMOKING CESSATION THERAPIES MEDICAID REQUIRED COVERAGE included in the latest version of S 1415, the National Tobacco Policy and Youth Smoking Reduction Act, brought to the Senate floor May 18. Under the manager's amendment, the bill would amend section 1927(d) of the Public Health Service Act, which allows states to exclude OTCs from Medicaid coverage, so that states may exclude all OTC drugs "except agents, approved by the Food and Drug Administration, when used to promote smoking cessation." States also would be required to cover Rx smoking cessation products. The Senate was scheduled to resume consideration of the legislation when it returned from recess June 1.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning